LOGO
LOGO

Quick Facts

GeneDx Holdings Announces Prelim. Q4, FY25 Revenue, Provides FY26 Revenue Outlook

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News

GeneDx Holdings Corp. (WGS), Monday announced preliminary financial results, reporting revenues of approximately $427 million and $121 million for full year 2025 and fourth quarter, respectively.

The company noted that revenues increased by 41 percent and 27 percent year-over-year in full year 2025 and fourth quarter, respectively.

On average, analysts estimate revenues of $427.04 million and $120.49 million for full year 2025 and fourth quarter, respectively.

Looking ahead, the company expects revenue of $540 to $555 million for full year 2026.

Analysts, on average, anticipate revenue of $531.02 million for full year 2026.

In the pre-market hours, WGS is trading at $124.01, down 8.40 percent on the Nasdaq.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Global Economics Weekly Update - January 05- 09, 2026

January 09, 2026 15:02 ET
U.S. external trade data and labor market figures were in focus this week as the news flow gained momentum in the new year. In Europe, inflation data for the euro area was the highlight. The single-currency bloc expanded to 21 countries this year with Bulgaria adopting the currency on January 1. News flow in Asia was dominated by the survey data on the Chinese services industry.

RELATED NEWS
Latest Updates on COVID-19